Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer

Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..

BACKGROUND/AIM: The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic.

PATIENTS AND METHODS: Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep disorders.

RESULTS: Sleep disorders were significantly associated with age ≤60 years (p=0.006); high distress score (p<0.0001); more emotional (p<0.0001), physical (p<0.0001) or practical (p<0.0001) problems; psycho-oncological need (p<0.0001); invasive cancer (p=0.003); chemotherapy (p<0.001); and hormonal therapy (p=0.006). Sleep disorders were similarly common in both groups (prior to vs. during the pandemic: 40% vs. 45%, p=0.38).

CONCLUSION: Although additional significant risk factors for sleep disorders were identified, the COVID-19 pandemic appeared to have no significant impact on sleep disorders in patients scheduled for irradiation of breast cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

In vivo (Athens, Greece) - 35(2021), 4 vom: 12. Juli, Seite 2253-2260

Sprache:

Englisch

Beteiligte Personen:

Rades, Dirk [VerfasserIn]
Narvaez, Carlos A [VerfasserIn]
Schild, Steven E [VerfasserIn]
Tvilsted, Soeren [VerfasserIn]
Kjaer, Troels W [VerfasserIn]

Links:

Volltext

Themen:

Breast cancer
COVID-19 pandemic
Journal Article
Pre-radiotherapy sleep disorders
Prevalence
Risk factors

Anmerkungen:

Date Completed 30.06.2021

Date Revised 03.08.2021

published: Print

Citation Status MEDLINE

doi:

10.21873/invivo.12498

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327295082